Drugs / VRC rAd5 vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01479296 | Dec 2011 → May 2013 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VRC rAd5 vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01479296 ↗ |
| Modality | Vaccine | “The VRC rAd5 HIV vaccine contains four different components.” NCT01479296 ↗ |
| Route | Intramuscular | “Given intramuscularly” NCT01479296 ↗ |